Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS).

There is evidence that motor and premotor cortex are hyperexcitable in obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). We tested whether low-frequency repetitive transcranial magnetic stimulation (rTMS) could normalize overactive motor cortical regions and thereby improve symptoms. Subjects with OCD or TS were treated with active rTMS to the supplementary motor area (SMA) for 10 daily sessions at 1 Hz, 100% of motor threshold, 1200 stimuli/day. Suggestions of clinical improvement were apparent as early as the first week of rTMS. At the second week of treatment, statistically significant reductions were seen in the YBOCS, YGTSS, CGI, HARS, HDRS, SAD, BDI, SCL-90, and SASS. Symptoms improvement was correlated with a significant increase of the right resting motor threshold and was stable at 3 months follow-up. Slow rTMS to SMA resulted in a significant clinical improvement and a normalization of the right hemisphere hyperexcitability, thereby restoring hemispheric symmetry in motor threshold.

[1]  S. Rossi,et al.  Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder , 2005, Biological Psychiatry.

[2]  J. Rothwell,et al.  Increased corticospinal excitability after 5 Hz rTMS over the human supplementary motor area , 2005, Journal of Physiology.

[3]  J. Rothwell,et al.  Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp. , 2004, Brain : a journal of neurology.

[4]  S. Woods,et al.  Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder. , 2004, The American journal of psychiatry.

[5]  Xingbao Li,et al.  A Pilot Safety Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Tourette’s Syndrome , 2004, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[6]  S. Haber.  The primate basal ganglia: parallel and integrative networks , 2003, Journal of Chemical Neuroanatomy.

[7]  T. Paus,et al.  Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. , 2003, Brain : a journal of neurology.

[8]  H. Mayberg.  Positron emission tomography imaging in depression: a neural systems perspective. , 2003, Neuroimaging clinics of North America.

[9]  Hae-Jeong Park,et al.  Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive–compulsive disorder , 2003, Acta psychiatrica Scandinavica.

[10]  C. Babiloni,et al.  Influence of the supplementary motor area on primary motor cortex excitability during movements triggered by neutral or emotionally unpleasant visual cues , 2003, Experimental Brain Research.

[11]  J. Rothwell,et al.  Repetitive transcranial magnetic stimulation for Tourette syndrome , 2002, Neurology.

[12]  E. Hollander,et al.  Treatment non-response in OCD: methodological issues and operational definitions. , 2002, The international journal of neuropsychopharmacology.

[13]  A Jon Stoessl,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Placebos and the Placebo Effect the Placebo Effect in Neurological Disorders , 2022 .

[14]  Sung-Cheng Huang,et al.  Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. , 2002, Archives of general psychiatry.

[15]  P. Mitchell,et al.  Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder: a preliminary investigation. , 2001, The Journal of clinical psychiatry.

[16]  P. Strick,et al.  Imaging the premotor areas , 2001, Current Opinion in Neurobiology.

[17]  J. Pujol,et al.  Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study. , 2001, The American journal of psychiatry.

[18]  F. Volkmar.  What is a "placebo controlled" study? , 2001, Journal of autism and developmental disorders.

[19]  L. S. Boylana,et al.  Repetitive transcranial magnetic stimulation to SMA worsens complex movements in Parkinson ' s disease , 2001 .

[20]  B. Greenberg,et al.  Altered cortical excitability in obsessive–compulsive disorder , 2000, Neurology.

[21]  J. Bradshaw,et al.  Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology? , 1999, Clinical psychology review.

[22]  D. Murphy,et al.  Decreased neuronal inhibition in cerebral cortex in obsessive compulsive disorder on transcranial magnetic stimulation , 1998, The Lancet.

[23]  F. Rubia,et al.  Technetium-99m-HMPAO in Tourette's syndrome on neuroleptic therapy and after withdrawal. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  A Rothenberger,et al.  Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. , 1997, The American journal of psychiatry.

[25]  D. Murphy,et al.  Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. , 1997, The American journal of psychiatry.